Open House Biologika discount agreements 2026 - 12 Epoetin alfa and Epoetin zeta

Summary

The tender concerns discount agreements for Epoetin alfa and Epoetin zeta medicines. This is a TK open-house procedure in which contracts are concluded with all suitable pharmaceutical companies on uniform terms, without individual negotiations and without exclusivity. The contract term is up to 24 months from 01/07/2026 and ends no later than 30/06/2028. The bidder must be a pharmaceutical company, have a valid authorisation to place the offered medicines on the market, and confirm its reliability and the absence of exclusion grounds.